- English version
- Articles
- Innovations
- Note to the businessman
- Northwest becomes an outpost of biopharma development
Related posts
-
Pharmaceutical business: Risk management
Merck has released the results of a survey on how to manage new risks associated with the changing landscape of the biopharmaceutical industry.
08 June 2016 -
Biopharmaceutics: a premonition of a bubble
Last year, the shares of companies at the preliminary testing stage or in Phase 1 on the first day of trading grew by an average of 29%. The situation is somewhat reminiscent of the famous dot-com bubble, when stocks soared by 50-70% on the first day of trading
14 September 2015 -
Union of Four
Four regional biopharmaceuticals have merged into the Siberian Biotechnological Initiative in the hope of receiving federal support. However, the sources of funding have not yet been determined.
21 May 2015 -
Biobusinessincubator in Dolgoprudny
The Biobusinessincubator will create corporate laboratories of cluster members, host the first startups, which will have to gain momentum by 2014 and become part of the biopharmaceutical corps.
18 May 2012 -
Biotechnology of Switzerland: no way without small
The biotechnology industry of one of the world's leading pharmaceutical companies – Switzerland – is based on small innovative companies.
11 July 2008